Aphea.Bio

Challenge the conventional. Change the norm.

Ghent, Belgium · Founded 2016 · $104.3M raised

Headquarters
Ghent
Employees
51–200
Founded
2016
Business Model
B2B
Website
aphea.bio
Total Funding
$104.3M
Last Round
$70.0M Series CJul 2023
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Aphea.Bio was founded in December 2016 by Isabel Vercauteren (CEO) and Steven Vandenabeele (CTO) as a spin-off of VIB (Flemish Institute for Biotechnology) and partner universities Ghent University and KU Leuven. Located in the biotech cluster in Ghent, Belgium, the company develops biological crop protection solutions using its proprietary APEXbio™ high-throughput R&D platform. Aphea.Bio's product pipeline includes biostimulants, biofungicides, bioherbicides, and bioinsecticides derived from natural microorganisms. Key commercial products include ACTIV by APHEA bio® (biostimulant seed treatment) and INITIΛ by Aphea.Bio™. The company secured €70 million in Series C funding led by Innovation Industries, with participation from Korys Investments, the Bill & Melinda Gates Foundation, SFPIM, and BNP Paribas Fortis. Aphea.Bio is a Certified B Corporation with a score of 94.5 and employs 50+ scientists and industry specialists.

Summary

Aphea.Bio is an Agtech company based in Ghent, Belgium, founded in 2016. It has raised $104.3M in total across 5 rounds, most recently a $70.0M Series C round in Jul 2023. Investors include ECBF, Astanor Ventures and V-Bio Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJul 2023
$70.0M

Sign up to see all 5 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United States501–1000Agtech, Biotech
Series G+Total funding$1.9BNov 2021
Apeel Sciences

Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...

GOLETA, United States201–500Agtech, Biotech
Series FTotal funding$912.9MJul 2025
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aphea.Bio on Indexed.vc
<a href="https://indexed.vc/companies/aphea-bio"><img src="https://indexed.vc/api/badge/company/aphea-bio" alt="Aphea.Bio on Indexed.vc" width="260" height="76" /></a>